| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |